{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:29:33Z","timestamp":1753889373418},"reference-count":0,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma","GLAL"],"published-print":{"date-parts":[[1995,5,1]]},"DOI":"10.3109\/10428199509056851","type":"journal-article","created":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T01:32:37Z","timestamp":1195435957000},"page":"411-415","source":"Crossref","is-referenced-by-count":4,"title":["Interleukin-2 Therapy for Myelodysplastic Syndrome: Does It Work?"],"prefix":"10.1080","volume":"17","author":[{"given":"Kiyoyuki","family":"Ogata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Yokose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","container-title":["Leukemia and Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428199509056851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T18:31:01Z","timestamp":1481826661000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428199509056851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,5,1]]}},"alternative-id":["785152359"],"URL":"https:\/\/doi.org\/10.3109\/10428199509056851","relation":{},"ISSN":["1042-8194"],"issn-type":[{"value":"1042-8194","type":"print"}],"subject":[],"published":{"date-parts":[[1995,5,1]]}}}